Results
|
1281.
|
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia. [electronic resource] by
- Krug, U
- Berdel, W E
- Gale, R P
- Haferlach, C
- Schnittger, S
- Müller-Tidow, C
- Braess, J
- Spiekermann, K
- Staib, P
- Beelen, D
- Serve, H
- Schliemann, C
- Stelljes, M
- Balleisen, L
- Maschmeyer, G
- Grüneisen, A
- Eimermacher, H
- Giagounidis, A
- Rasche, H
- Hehlmann, R
- Lengfelder, E
- Thiel, E
- Reichle, A
- Aul, C
- Ludwig, W-D
- Kern, W
- Haferlach, T
- Köpcke, W
- Görlich, D
- Sauerland, M C
- Heinecke, A
- Wörmann, B J
- Hiddemann, W
- Büchner, T
Producer: 20170829
In:
Leukemia vol. 30
Availability: No items available.
|
|
1282.
|
|
|
1283.
|
Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses. [electronic resource] by
- Strocchi, E
- Camaggi, C M
- Martoni, A
- Cellerino, R
- Miseria, S
- Malacarne, P
- Indelli, M
- Balli, M
- Bonciarelli, G
- Ambroso, G
Producer: 19910516
In:
Cancer chemotherapy and pharmacology vol. 27
Availability: No items available.
|
|
1284.
|
|
|
1285.
|
|
|
1286.
|
|
|
1287.
|
Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report. [electronic resource] by
- Coombes, R C
- Chilvers, C
- Dowsett, M
- Gazet, J C
- Ford, H T
- Bettelheim, R
- Gordon, C
- Smith, I E
- Zava, D
- Powles, T J
Producer: 19820826
In:
Cancer research vol. 42
Availability: No items available.
|
|
1288.
|
|
|
1289.
|
|
|
1290.
|
|
|
1291.
|
|
|
1292.
|
|
|
1293.
|
|
|
1294.
|
|
|
1295.
|
Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment. [electronic resource] by
- Arroyo-Crespo, Juan J
- Armiñán, Ana
- Charbonnier, David
- Balzano-Nogueira, Leandro
- Huertas-López, Francisco
- Martí, Cristina
- Tarazona, Sonia
- Forteza, Jerónimo
- Conesa, Ana
- Vicent, María J
Producer: 20190719
In:
Biomaterials vol. 186
Availability: No items available.
|
|
1296.
|
|
|
1297.
|
|
|
1298.
|
|
|
1299.
|
Letrozole, a new oral aromatase inhibitor: randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer. Letrozole International Trial Group (AR/BC3). [electronic resource] by
- Gershanovich, M
- Chaudri, H A
- Campos, D
- Lurie, H
- Bonaventura, A
- Jeffrey, M
- Buzzi, F
- Bodrogi, I
- Ludwig, H
- Reichardt, P
- O'Higgins, N
- Romieu, G
- Friederich, P
- Lassus, M
Producer: 19981015
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 9
Availability: No items available.
|
|
1300.
|
|